Author:
dos Santos Dias Paula Danniele,de Santana Mary Elizabeth,de Azevedo Lima Vera Lúcia
Abstract
Objective. To analyze whether the COVID-19 pandemic had an impact on the screening, diagnosis and treatment of breast cancer in women up to 50 years of age in the state of Pará. Methods. Retrospective, cross-sectional study with a quantitative approach, using data from the Information Technology Department of the Brazilian Unified Health System. (DATASUS). The number of exams carried out in the pre-pandemic (2018-2019) and pandemic (2020-2021) period was analyzed based on the percentage variation, application of the chi-square test and G test for the time of exams and start time of treatment. Results. During the pandemic period, there was a greater number of screening mammograms (+3.68%), cytological (+23.68%), histological (+10.7%) and a lower number of diagnostic mammograms (-38.7%). The time interval for carrying out the exams was up to 30 days for screening and diagnostic exams and more than 60 days to start treatment during the pandemic period. Conclusion. Although the results indicate an increase in the number of screening and diagnostic procedures for breast cancer during the pandemic period, with the exception of diagnostic mammography, when considering probability values, the study points out that statistically the COVID-19 pandemic did not interfere with actions of breast cancer, in women over 50 years of age, in the state of Pará. Considering the autonomy of nursing and its role in public health, it is up to the professionals who are in charge of primary care programs to implement contingency plans in periods of crisis so that the population is not left unassisted.
Reference23 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;A Cancer Journal for Clinicians,2021
2. 2 A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro; 2019.
3. 3 Estimativa 2020: Incidência de câncer no Brasil. Rio de Janeiro; 2019.
4. 4 Estimativa 2023: Incidência de câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro; 2022.
5. 5 Lucas F, Bergmann A, Bello M, Tonellotto F, Caiado Neto B. Reconstrução Mamária em Pacientes Oncológicos durante a Pandemia da Covid-19. Revista Brasileira de Cancerologia. 2020; 66 (Tema Atual):e-1004.